Literature DB >> 7090985

Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.

S Swiryn, R A Bauernfeind, B Strasberg, E Palileo, N Iverson, P S Levy, K M Rosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7090985     DOI： 10.1016/0002-8703(82)90639-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  5 in total

Review 1.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Programmed ventricular stimulation after myocardial infarction does not help reduce the risk of ventricular events.

Authors:  B Brembilla-Perrot; L Jacquemin; A Terrier de la Chaise; D Beurrier
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 3.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

4.  Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens.

Authors:  B Brembilla-Perrot; E Aliot; J Clementy; P Cosnay; P Djiane; J P Fauchier; S Kacet; D Lellouche; P Mabo; M Richard
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

5.  A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.

Authors:  L J Jordaens; F Colardyn; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.